Riskpilot← Back to searchSign inGet full accessLP-INVEST AS
ASActiveOrg 992877049Nordre Furudalen 3, 5099 BergenResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20080 employees
Revenue 2024
NOK 0
EBITDA margin
—
+23% vs 2023
Equity ratio
99.7%
Financial strength
Net profit 2024
NOK -212K
+69% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -19K | +23% |
| Net profit | NOK -212K | +69% |
| Total assets | NOK 2,7M | -7% |
| Equity | NOK 2,7M | -7% |
| Employees | 0 | — |
Legal name
LP-INVEST AS
Org number
992877049
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9. juli 2008
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Konsulenttjenester innenfor bioteknologi, legemiddelindustri og livsvitenskap, samt drive med kursvirksomhet og foredrag innen disse sektorene. Selskapet kan også investere i aksjer, obligasjoner og andre verdipapirer, samt kunne foreta investering i fast eiendom.
Address
Nordre Furudalen 3, 5099 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 148 | 2 304 | 1 736 | 0 | 0 |
| Staff expenses | −1 093 | −1 240 | −1 080 | −0 | −0 |
| EBITDA | 1 019 | 1 035 | 604 | −24 | −19 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 019 | 1 035 | 604 | −24 | −19 |
| Net financials | −185 | −817 | −424 | −657 | −193 |
| Profit before tax | 834 | 219 | 180 | −681 | −212 |
| Tax | 215 | 228 | 132 | −0 | −0 |
| Net profit | 618 | −9 | 48 | −681 | −212 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 004 | 3 907 | 3 931 | 2 871 | 2 659 |
| Equity | 3 505 | 3 496 | 3 544 | 2 863 | 2 651 |
| Long-term debt | 116 | 5 | 255 | 8 | 8 |
| Short-term debt | 383 | 406 | 132 | 0 | 0 |
| Total debt | 498 | 411 | 388 | 8 | 8 |
EBITDA margin
-1854300.0%
This company
15.8%
Market median
-11736176% vs market
20202024
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
-8.0%
This company
18.4%
Market median
-143% vs market
20202024
Net profit margin
-21203200.0%
This company
8.1%
Market median
-261768001% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AD Deputy Member | Deputy Member | 2008 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2008 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LP-INVEST AS 
Cytovation AsaBoard members of LP-INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anja Drozdik | Deputy Member | 0 companies |
| Lars Prestegarden | Chairman | 0 companies |